Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 · Hepatology · 10K citations
https://doi.org/10.1002/hep.20701
M
Mark L. Van Natta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
28.6K
Citations
55
h-index
114
i10-index
Mark L. Van Natta is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cytomegalovirus and herpesvirus research & Ocular Diseases and Behçet’s Syndrome. The author has an h-index of 55, co-authored 146 publications.
ORCID: 0000-0002-3219-9451Papers by this author
worksPioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 · New England Journal of Medicine · 3,223 citations
https://doi.org/10.1056/nejmoa0907929
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
2021 · New England Journal of Medicine · 986 citations
https://doi.org/10.1056/nejmoa2029349
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
2018 · Clinical Gastroenterology and Hepatology · 580 citations
https://doi.org/10.1016/j.cgh.2018.04.043
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
2014 · The Journal of Infectious Diseases · 468 citations
https://doi.org/10.1093/infdis/jiu238
Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage
2019 · Clinical Gastroenterology and Hepatology · 258 citations
https://doi.org/10.1016/j.cgh.2018.12.031
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat